Results 71 to 80 of about 2,519,772 (150)

Beyond Weight Loss: Tirzepatide as a Metabolic Disease‐Modifying Strategy for Metabolic Dysfunction‐Associated Steatohepatitis: A Narrative Review

open access: yesHealth Science Reports, Volume 9, Issue 8, August 2026.
ABSTRACT Background Metabolic dysfunction‐associated steatotic liver disease (MASLD) has emerged as the most prevalent chronic liver disease worldwide and a major contributor to liver‐related morbidity and mortality. Its progressive subtype, metabolic dysfunction–associated steatohepatitis (MASH), is characterized by hepatocellular injury, inflammation,
Zubaier Ahmed   +3 more
wiley   +1 more source

Bile Acid Receptor Therapeutics Effects on Chronic Liver Diseases

open access: yesFrontiers in Medicine, 2020
In the past ten years, our understanding of the importance of bile acids has expanded from fat absorption and glucose/lipid/energy homeostasis into potential therapeutic targets for amelioration of chronic cholestatic liver diseases.
Vik Meadows   +7 more
doaj   +1 more source

Obeticholic acid for the treatment of primary biliary cirrhosis

open access: yes
Introduction: There is significant unmet need in Primary Biliary Cholangitis (PBC) in patients under-responsive to the only approved therapy Ursodeoxycholic Acid (UDCA) who are at increased risk of progressing to end-stage liver disease. Obeticholic Acid
Jones DEJ
core   +4 more sources

Primary Biliary Cholangitis With Incomplete Response to Conventional Therapies But Had Complete Response to Baricitinib: A Case Report

open access: yesCase Reports in Hepatology
Primary biliary cholangitis is a progressive disease with complications such as liver cirrhosis and hepatocellular carcinoma, and the treatment goal is to delay its progression.
Gi Eun Kim   +3 more
doaj   +1 more source

Multiple roles of bile acids in ferroptosis regulation: Opportunities for disease therapy

open access: yesPharmacological Research
Bile acids (BAs), the main component of bile, play a key role in the digestion of lipids. However, recent studies have demonstrated that BAs can also act as signaling molecules, regulating metabolism by binding to BA receptors.
Nan Wu   +4 more
doaj   +1 more source

The use of obeticholic acid for the management of non-viral liver disease: current clinical practice and future perspectives

open access: yes, 2017
Introduction: Farnesoid X nuclear receptor is involved in the regulation of lipid and glucose metabolism, though mainly in the homeostasis of bile acids. Indeed, the agonists of farnesoid X nuclear receptor represent promising drugs.
Stefano Gitto   +7 more
core   +1 more source

Obeticholic acid for the treatment of primary biliary cirrhosis [PDF]

open access: yes, 2016
Primary biliary cirrhosis (PBC) is characterized by progressive nonsuppurative destruction of small bile ducts, resulting in intrahepatic cholestasis, fibrosis and ultimately end-stage liver disease.
Hirschfield, Gideon M   +2 more
core   +1 more source

Role of Farnesoid X Receptor Ligand Obeticholic Acid Versus Vitamin E for Patients with Nonalcoholic Steatohepatitis [PDF]

open access: yesAl-Azhar International Medical Journal
Background: Non-alcoholic fatty liver disease (NAFLD) is a leading metabolic disorder that commonly progresses to non-alcoholic steatohepatitis (NASH), potentially complicated with cirrhosis, liver failure, and hepatocellular carcinoma.Aim: To compare ...
doaj   +1 more source

Obeticholic acid reduces bacterial traslocation, restores intestinal barrier and inhibits inflammation in cirrhotic rats

open access: yes, 2016
9 p.Background & aims: In advanced cirrhosis, gut bacterial translocation is the consequence of intestinal barrier disruption and leads to bacterial infection.
Pastor Rojo, Óscar   +12 more
core   +1 more source

Supplementary_Material – Supplemental material for Synthesis and characterization of new impurities in obeticholic acid

open access: yes, 2019
Supplemental material, Supplementary_Material for Synthesis and characterization of new impurities in obeticholic acid by Wei-Dong Feng, Song-Ming Zhuo and Fu-Li Zhang in Journal of Chemical ...
Wei-Dong Feng (5635334)   +2 more
core   +1 more source

Home - About - Disclaimer - Privacy